Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers (Q50525085)
Jump to navigation
Jump to search
scientific article published on 28 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers |
scientific article published on 28 March 2016 |
Statements
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers (English)
1 reference
William L Klein
1 reference
Tomohiro Umeda
1 reference
Kenjiro Ono
1 reference
Ayumi Sakai
1 reference
Minato Yamashita
1 reference
Mineyuki Mizuguchi
1 reference
Masahito Yamada
1 reference
Hiroshi Mori
1 reference
Takami Tomiyama
1 reference
28 March 2016
1 reference
1 reference
139
1 reference
Pt 5
1 reference
1568-1586
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference